Taken together, our findings indicate that in the absence of bacterial infection, corrector molecules can reduce the inflammatory profile of CFBE-F508del cells by selectively downregulating the production and secretion of IL-6 and IL-17A. Here, IL17A is linked to bacterial infectious disease.